Bruce F. Scharschmidt

6.4k total citations
116 papers, 4.6k citations indexed

About

Bruce F. Scharschmidt is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bruce F. Scharschmidt has authored 116 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 35 papers in Oncology and 28 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bruce F. Scharschmidt's work include Drug Transport and Resistance Mechanisms (34 papers), Neonatal Health and Biochemistry (23 papers) and Liver Disease Diagnosis and Treatment (22 papers). Bruce F. Scharschmidt is often cited by papers focused on Drug Transport and Resistance Mechanisms (34 papers), Neonatal Health and Biochemistry (23 papers) and Liver Disease Diagnosis and Treatment (22 papers). Bruce F. Scharschmidt collaborates with scholars based in United States, Germany and Switzerland. Bruce F. Scharschmidt's co-authors include Rebecca W. Van Dyke, Nancy M. Blankenship, Robert K. Ockner, John R. Lake, John Fitz, Jeanne G. Waggoner, E B Keeffe, P D Berk, Emmet B. Keeffe and Eberhard L. Renner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Bruce F. Scharschmidt

113 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce F. Scharschmidt United States	40	1.5k	1.3k	1.2k	1.1k	1.1k	116	4.6k
Barbara H. Billing United Kingdom	31	1.1k 0.7×	739 0.6×	935 0.8×	750 0.7×	828 0.8×	83	3.5k
P. L. M. Jansen Netherlands	34	1.0k 0.7×	898 0.7×	1.7k 1.3×	639 0.6×	764 0.7×	79	3.8k
Allan W. Wolkoff United States	48	2.4k 1.6×	983 0.8×	3.3k 2.7×	486 0.4×	852 0.8×	146	6.8k
N M Bass United States	33	1.4k 0.9×	738 0.6×	584 0.5×	942 0.9×	922 0.9×	68	3.5k
I. A. D. Bouchier United Kingdom	37	674 0.4×	1.5k 1.2×	835 0.7×	915 0.8×	1.2k 1.2×	170	4.0k
G Strohmeyer Germany	35	909 0.6×	1.2k 0.9×	668 0.5×	596 0.5×	1.3k 1.3×	193	5.8k
Charles W. Putnam United States	35	1.1k 0.7×	1.8k 1.4×	649 0.5×	1.1k 1.0×	632 0.6×	120	4.5k
Niels Grunnet Denmark	40	1.1k 0.7×	662 0.5×	343 0.3×	280 0.3×	727 0.7×	217	5.1k
Junichi Shoda Japan	42	1.3k 0.9×	1.6k 1.3×	1.4k 1.1×	1.2k 1.1×	1.6k 1.5×	152	5.0k
Verena Keitel Germany	40	1.2k 0.8×	2.2k 1.7×	2.9k 2.3×	1.5k 1.4×	1.7k 1.6×	166	5.5k

Countries citing papers authored by Bruce F. Scharschmidt

Since Specialization

Citations

This map shows the geographic impact of Bruce F. Scharschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce F. Scharschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce F. Scharschmidt more than expected).

Fields of papers citing papers by Bruce F. Scharschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce F. Scharschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce F. Scharschmidt. The network helps show where Bruce F. Scharschmidt may publish in the future.

Co-authorship network of co-authors of Bruce F. Scharschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce F. Scharschmidt. A scholar is included among the top collaborators of Bruce F. Scharschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce F. Scharschmidt. Bruce F. Scharschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vierling, John M., Masoud Mokhtarani, Robert S. Brown, et al.. (2015). Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 14(6). 903–906.e1. 48 indexed citations

Mokhtarani, Masoud, George A. Díaz, Uta Lichter‐Konecki, et al.. (2015). Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate. SHILAP Revista de lepidopterología. 5. 12–14. 3 indexed citations

Ghabril, Marwan, И. А. Зупанец, John M. Vierling, et al.. (2013). Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration. Clinical Pharmacology in Drug Development. 2(3). 278–284. 21 indexed citations

Smith, Wendy E., George A. Díaz, Uta Lichter‐Konecki, et al.. (2013). Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate. The Journal of Pediatrics. 162(6). 1228–1234.e1. 33 indexed citations

Lee, Brendan, William J. Rhead, George A. Díaz, et al.. (2010). Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control. Molecular Genetics and Metabolism. 100(3). 221–228. 72 indexed citations

McGuire, Brendan M., И. А. Зупанец, Mark E. Lowe, et al.. (2010). Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults With Cirrhosis. Hepatology. 51(6). 2077–2085. 57 indexed citations

Rosenkranz, Bernd, Peter Malfertheiner, Viola Schultze, et al.. (2003). Phase I Safety and Immunogenicity of A Three‐Component H. Pylori Vaccine. Clinical Pharmacology & Therapeutics. 73(2). 6 indexed citations

Cavalieri, Ralph R., Luiz Alberto Simeoni, John D. Baxter, et al.. (1999). Thyroid Hormone Export in Rat FRTL-5 Thyroid Cells and Mouse NIH-3T3 Cells Is Carrier-Mediated, Verapamil-Sensitive, and Stereospecific1. Endocrinology. 140(11). 4948–4954. 18 indexed citations

Bull, Laura N., Noureddine Lomri, Thomas Luther, et al.. (1996). In Search of a Gene for Hereditary Cholestasis. Biochemical and Molecular Medicine. 59(2). 98–103. 5 indexed citations

10.

Bass, Nathan M., Marie Csete Prager, Denna E. Washington, et al.. (1992). Intracranial Pressure Monitoring and Liver Transplantation for Fulminant Hepatic Failure. Hepatology. 16(1). 1–7. 182 indexed citations

11.

Renner, Eberhard L., et al.. (1989). Rat hepatocytes exhibit basolateral Na+/HCO3- cotransport.. Journal of Clinical Investigation. 83(4). 1225–1235. 62 indexed citations

12.

Scharschmidt, Bruce F., Edwin R. Griff, & Roy H. Steinberg. (1988). Effect of taurine on the isolated retinal pigment epithelium of the frog: Electrophysiologic evidence for stimulation of an apical, electrogenic Na+−K+ pump. The Journal of Membrane Biology. 106(1). 71–81. 14 indexed citations

13.

Renner, Eberhard L., John R. Lake, Edward J. Cragoe, & Bruce F. Scharschmidt. (1988). Amiloride and amiloride analogs inhibit Na+/K+-transporting ATPase and Na+-coupled alanine transport in rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 938(3). 386–394. 38 indexed citations

14.

Lake, John R., Rebecca W. Van Dyke, & Bruce F. Scharschmidt. (1987). Acidic Vesicles in Cultured Rat Hepatocytes. Gastroenterology. 92(5). 1251–1261. 38 indexed citations

15.

Niederau, Claus, Rebecca W. Van Dyke, Bruce F. Scharschmidt, & James H. Grendell. (1986). Rat pancreatic zymogen granules. Gastroenterology. 91(6). 1433–1442. 3 indexed citations

16.

Niederau, Claus, Rebecca W. Van Dyke, Bruce F. Scharschmidt, & James H. Grendell. (1986). Rat pancreatic zymogen granules. Gastroenterology. 91(6). 1433–1442. 20 indexed citations

17.

Scharschmidt, Bruce F., Norbert Blanckaert, Franco Farina, et al.. (1979). Measurement of mono conjugated di conjugated and unconjugated bilirubin ix alpha in normal and hyper bilirubinemic serum. Gastroenterology. 77(5). 39. 1 indexed citations

18.

Scharschmidt, Bruce F., E B Keeffe, Nancy M. Blankenship, & Robert K. Ockner. (1979). Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity.. PubMed. 93(5). 790–9. 331 indexed citations

19.

Wolkoff, Allan W., et al.. (1978). Studies of the kinetics of purified conjugated bilirubin-3H in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 70(3). 259–64. 14 indexed citations

20.

Scharschmidt, Bruce F., E B Keeffe, Nancy M. Blankenship, & Robert K. Ockner. (1978). Taurocholate: A rapid regulator of canalicular hembrane NaK-ATPase activity. Gastroenterology. 74(5). 1167. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact